Safety, pharmacokinetics, and antimalarial activity of the novel plasmodium eukaryotic translation elongation factor 2 inhibitor M5717: a first-in-human, randomised, placebo-controlled, double-blind, single ascending dose study and volunteer infection study
Titel:
Safety, pharmacokinetics, and antimalarial activity of the novel plasmodium eukaryotic translation elongation factor 2 inhibitor M5717: a first-in-human, randomised, placebo-controlled, double-blind, single ascending dose study and volunteer infection study
Auteur:
McCarthy, James S Yalkinoglu, Özkan Odedra, Anand Webster, Rebecca Oeuvray, Claude Tappert, Aliona Bezuidenhout, Deon Giddins, Marla J Dhingra, Satish K Fidock, David A Marquart, Louise Webb, Lachlan Yin, Xiaoyan Khandelwal, Akash Bagchus, Wilhelmina M
Verschenen in:
The lancet infectious diseases
Paginering:
Jaargang 21 () nr. 12 pagina's 1713-1724
Jaar:
2021
Inhoud:
Uitgever:
The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license